TABLE 2.

Absorbed Radiation Doses of ¹⁷⁷Lu-PP-F11N in Tumors, Kidneys, Stomach, and Bone Marrow Without and With Coadministration of SG

	Mean tumor dose (Gy/GBq)/patient		Mean kidney dose (Gy/GBq)/patient		Stomach dose (Gy/GBq)		Bone marrow dose (Gy/GBq)		Tumor-to-kidney dose ratio		Tumor-to-stomach dose ratio		Tumor-to-bone marrow dose ratio
Patient	Without SG	With SG	Without SG	With SG	Without SG	With SG	Without SG	With SG	Without SG	With SG	Without SG	With SG	Without SG	With SG
1	1.09	1.04	0.15	0.11	0.45	0.50	0.022	0.025	7.27	9.45	2.42	2.08	49.6	41.6
2	3.59	1.42	0.13	0.07	0.38	0.47	0.025	0.028	27.6	20.3	9.45	3.02	143.6	50.7
3	0.90	0.67	0.06	0.05	1.66	1.46	0.028	0.031	15.0	13.4	0.54	0.46	32.1	21.6
4	0.85	0.64	0.08	0.10	0.20	0.18	0.044	0.039	10.6	6.4	4.25	3.56	19.3	16.4
5	0.85	1.03	0.13	0.05	1.2	2.07	0.036	0.039	6.5	20.6	0.71	0.50	23.6	26.4
6	0.63	0.63	0.05	0.05	0.13	0.26	0.028	0.033	12.6	12.6	4.85	2.42	22.5	19.1
Median	0.88	0.85	0.11	0.06	0.42	0.49	0.028	0.032	11.6	13.0	3.34	2.25	27.9	24.0
IQR	0.85–1.04	0.65–1.04	0.07–0.13	0.05–0.09	0.25–1.01	0.31–1.22	0.026–0.034	0.025–0.038	8.11–14.4	10.2–18.6	1.14–4.70	0.90–2.87	19.3–45.2	16.4–37.8
Test for superiority(P)*	0.38		0.38		0.69		0.22		1.0		0.16		0.22

^*Two-sample paired sign test with significance level (α) of 0.05.